Does QUIZARTINIB Cause Platelet count decreased? 27 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 27 reports of Platelet count decreased have been filed in association with QUIZARTINIB (VANFLYTA). This represents 7.6% of all adverse event reports for QUIZARTINIB.
27
Reports of Platelet count decreased with QUIZARTINIB
7.6%
of all QUIZARTINIB reports
5
Deaths
12
Hospitalizations
How Dangerous Is Platelet count decreased From QUIZARTINIB?
Of the 27 reports, 5 (18.5%) resulted in death, 12 (44.4%) required hospitalization, and 2 (7.4%) were considered life-threatening.
Is Platelet count decreased Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for QUIZARTINIB. However, 27 reports have been filed with the FAERS database.
What Other Side Effects Does QUIZARTINIB Cause?
Off label use (47)
No adverse event (40)
Death (32)
Nausea (25)
Disease progression (20)
Pyrexia (20)
Electrocardiogram qt prolonged (19)
Febrile neutropenia (19)
Product dose omission issue (18)
Infection (17)
What Other Drugs Cause Platelet count decreased?
LENALIDOMIDE (7,491)
NIRAPARIB (4,102)
ELTROMBOPAG OLAMINE (3,419)
RUXOLITINIB (3,028)
RITUXIMAB (2,404)
VENETOCLAX (2,367)
DEXAMETHASONE (2,321)
PALBOCICLIB (2,277)
CYCLOPHOSPHAMIDE (1,894)
RIBAVIRIN (1,701)
Which QUIZARTINIB Alternatives Have Lower Platelet count decreased Risk?
QUIZARTINIB vs RABEPRAZOLE
QUIZARTINIB vs RACECADOTRIL
QUIZARTINIB vs RADIATION THERAPY
QUIZARTINIB vs RADIUM RA-223 DICHLORIDE
QUIZARTINIB vs RALOXIFENE